Literature DB >> 7986020

Reaction of antimalarial endoperoxides with specific parasite proteins.

W Asawamahasakda1, I Ittarat, Y M Pu, H Ziffer, S R Meshnick.   

Abstract

The endoperoxides are a new class of antimalarial agents, of which artemisinin (qinghaosu) is the prototype. We have previously shown that artemisinin is capable of alkylating proteins in model reactions. In the present study, we showed that when Plasmodium falciparum-infected erythrocytes are treated with a radiolabeled antimalarial endoperoxide, either arteether, dihydroartemisinin, or Ro 42-1611 (arteflene), the radioactivity is largely coverted into a form which can be extracted with sodium dodecyl sulfate (SDS). Autoradiograms of SDS-polyacrylamide gels showed that six malarial proteins are radioactively labeled by the three endoperoxides. This labeling occurs at physiological concentrations of drug and is not stage nor strain specific. The labeled proteins were not the most abundant proteins seen on Coomassie-stained gels. No proteins were labeled when uninfected erythrocytes were treated with these drugs, nor when infected erythrocytes were treated with the inactive analog deoxyarteether. Thus, the antimalarial endoperoxides appear to react with specific malarial proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986020      PMCID: PMC284649          DOI: 10.1128/AAC.38.8.1854

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Plasmodium falciparum (human malaria)-induced modifications in human erythrocyte band 3 protein.

Authors:  I Crandall; I W Sherman
Journal:  Parasitology       Date:  1991-06       Impact factor: 3.234

2.  Biochemical characterization of Plasmodium falciparum hemozoin.

Authors:  P Goldie; E F Roth; J Oppenheim; J P Vanderberg
Journal:  Am J Trop Med Hyg       Date:  1990-12       Impact factor: 2.345

3.  Hemin-catalyzed decomposition of artemisinin (qinghaosu).

Authors:  F Zhang; D K Gosser; S R Meshnick
Journal:  Biochem Pharmacol       Date:  1992-04-15       Impact factor: 5.858

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity.

Authors:  G H Posner; C H Oh; D Wang; L Gerena; W K Milhous; S R Meshnick; W Asawamahasadka
Journal:  J Med Chem       Date:  1994-04-29       Impact factor: 7.446

Review 6.  Qinghaosu.

Authors:  T T Hien; N J White
Journal:  Lancet       Date:  1993-03-06       Impact factor: 79.321

7.  A Plasmodium falciparum malaria vaccine candidate which contains epitopes from the circumsporozoite protein and a blood stage antigen, 5.1.

Authors:  P Caspers; H Etlinger; H Matile; J R Pink; D Stüber; B Takács
Journal:  Mol Biochem Parasitol       Date:  1991-08       Impact factor: 1.759

8.  Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle.

Authors:  D E Goldberg; A F Slater; A Cerami; G B Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

9.  Alkylation of human albumin by the antimalarial artemisinin.

Authors:  Y Z Yang; W Asawamahasakda; S R Meshnick
Journal:  Biochem Pharmacol       Date:  1993-07-20       Impact factor: 5.858

10.  Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu).

Authors:  S R Meshnick; Y Z Yang; V Lima; F Kuypers; S Kamchonwongpaisan; Y Yuthavong
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

View more
  47 in total

1.  Artemisinin and heme.

Authors:  Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

2.  Reaction of artemisinin with haemoglobin: implications for antimalarial activity.

Authors:  Rangiah Kannan; Krishan Kumar; Dinkar Sahal; Shrikant Kukreti; Virander S Chauhan
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

3.  Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii.

Authors:  D J Walker; J L Pitsch; M M Peng; B L Robinson; W Peters; J Bhisutthibhan; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin.

Authors:  Gundula Min-Oo; Anny Fortin; Jean-François Poulin; Philippe Gros
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

5.  Molecular understanding and modern application of traditional medicines: triumphs and trials.

Authors:  Timothy W Corson; Craig M Crews
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

6.  In vitro and in vivo potentiation of artemisinin and synthetic endoperoxide antimalarial drugs by metalloporphyrins.

Authors:  F Benoit-Vical; A Robert; B Meunier
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 7.  Safety assessment of peroxide antimalarials: clinical and chemical perspectives.

Authors:  B K Park; P M O'Neill; J L Maggs; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 8.  The role of plant-derived drugs and herbal medicines in healthcare.

Authors:  P A De Smet
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 9.  Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria.

Authors:  Richard T Eastman; David A Fidock
Journal:  Nat Rev Microbiol       Date:  2009-11-02       Impact factor: 60.633

10.  Artemisinin effectiveness in erythrocytes is reduced by heme and heme-containing proteins.

Authors:  Napawan Ponmee; Tatsanee Chuchue; Prapon Wilairat; Yongyuth Yuthavong; Sumalee Kamchonwongpaisan
Journal:  Biochem Pharmacol       Date:  2007-03-15       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.